Macy: Excuse me everyone, may I have your attention? We need to start our meeting.
Today, on our agenda, we will discuss the sales projection for quarter two, our upcoming conference with Mr. Johanson, and the upgrading of our software system. Let’s get started. Paul, can you go over the sales projections for quarter two?
Paul: Sure. The sales projections are as follows. We are doing very well in the European market with the Visor Elixir, however, they do not like the mint flavor. They prefer the cinnamon. Europeans prefer mint flavors and not spicy ones.
Cassie: Paul, Europeans do not like spicy flavors? I’m sure they like spicy flavors in Spain.
Paul: Well, they might like spicy flavors, it’s just the Visor Elixir Cinnamon flavor is not selling. I’m not sure what’s happening with this particular product. This is . I’m looking at the fact that the Mint flavor sold $3Million in sales and the Cinnamon flavor sold $900,000 in sales. So I think they don’t like the cinnamon flavor Elixir.
Macy: . Well, it might not be just the idea of something being spicy, it could be the flavor itself. Have you looked at other cinnamon flavored products? Like mouthwash or gum. How are those sales for this Johnson & Johnson product?
Cassie: Macy, I . I would also like to know the cinnamon flavored products for other companies too. That way we can determine if it’s the flavor of cinnamon or just the market location demographics.
Paul: I because our Visor Elixir is not considered pharmaceutical like most Johnson & Johnson products. Therefore, we are not comparing apples to apples. We are looking at apples and oranges. you can not compare Visor Elixir to mouthwash. They are not the same type of product.
Cassie: . Why can’t we compare the two? that we can not compare the two product flavors. We’re just comparing flavors to see if it’s the market of Europeans liking or not liking cinnamon or not. I know Visor Elixir is not a pharmaceutical.
Macy: Okay, it seems that Paul has to do some market research on these sales in Europe. and let Paul revise his report for next week. Now let’s move on to Mr. Johanson’s meeting with us next Monday, okay?
